Disease | gastroesophageal reflux disease |
Phenotype | C0004763|barrett\'s esophagus |
Sentences | 37 |
PubMedID- 21330224 | barrett's esophagus is the result of long-term acid reflux and is a precursor to esophageal adenocarcinoma. |
PubMedID- 25632808 | Increasing adiponectin levels were a risk factor for barrett's esophagus among patients with gerd (total adiponectin fourth vs first quartile odds ratio [or], 1.96; 95% confidence interval [ci], 1.17-3.27; high-molecular-weight adiponectin or, 1.65; 95% ci, 1.00-2.73; low-/medium-molecular-weight adiponectin or, 2.18; 95% ci, 1.33-3.56), but not compared with population controls. |
PubMedID- 21636532 | Gastroesophageal reflux is associated with adenocarcinoma in barrett's esophagus, but the incidence of this tumor is rising, despite widespread use of acid-suppressing medications. |
PubMedID- 21694467 | Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion. |
PubMedID- 23504527 | barrett's esophagus, with gastroesophageal reflux disease and obesity as risk factors, predisposes to esophageal adenocarcinoma (eac). |
PubMedID- 20680164 | A recent study assessed prevalence of acid and weakly acidic reflux in patients with short-segment barrett's esophagus. |
PubMedID- 22233658 | Symptom control alone does not manage acid reflux in patients with barrett's esophagus after surgery, and postoperative 24-hour ph-metry confirms acid reflux abolition. |
PubMedID- 20946664 | Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion. |
PubMedID- 23663216 | Having barrett's esophagus was associated with more severe gastroesophageal reflux symptoms, and nocturnal reflux symptoms were associated with scoring at high risk for obstructive sleep apnea. |
PubMedID- 26377193 | A newly identified susceptibility locus near foxp1 modifies the association of gastroesophageal reflux with barrett's esophagus. |
PubMedID- 20086178 | gastroesophageal reflux disease complicated by barrett's esophagus (be) is a major risk factor for esophageal adenocarcinoma (ea). |
PubMedID- 23318485 | Mutually adjusting for other covariates, barrett's esophagus was associated with weekly gerd (odds ratio (or)=2.33, 95% confidence interval (ci)=1.34, 4.05), age (or per 10 years=1.53, 95% ci=1.05, 2.25), waist-to-hip ratio (or per 0.10=1.44, 95% ci=0.898, 2.32) and pack-years of cigarette use (or per 10 pack-years=1.09, 95% ci=1.04, 1.14). |
PubMedID- 24428806 | barrett's esophagus (be) arising from chronic gastro-oesophageal reflux (gerd) is the main pathologic precursor of esophageal adenocarcinoma (eac). |
PubMedID- 20872963 | barrett's esophagus is a consequence of long standing gastro-esophageal reflux disease and predisposes to the development of esophageal adenocarcinoma. |
PubMedID- 20931428 | Conclusions: patients with progressive systemic sclerosis have a higher tendency to the more severe forms and complications of gastroesophageal reflux disease including barrett's esophagus than in those without progressive systemic sclerosis. |
PubMedID- 21309924 | Cim may represent a form of barrett's esophagus due to reflux or could reflect generalized gastric intestinal metaplasia due to helicobacter pylori. |
PubMedID- 22921670 | The relevance of weakly acidic reflux in patients with barrett's esophagus. |
PubMedID- 25804032 | [prospects for improving the management tactics for patients with gastroesophageal reflux disease complicated by barrett's esophagus]. |
PubMedID- 25349686 | Prevalence and risk factors for barrett's esophagus in patients with gerd in northern india; do methylene blue-directed biopsies improve detection of barrett's esophagus compared the conventional method. |
PubMedID- 26032153 | Control of acid and duodenogastroesophageal reflux (dger) in patients with barrett's esophagus. |
PubMedID- 21927653 | Because gerd may lead to reflux esophagitis, barrett's esophagus and esophageal adenocarcinoma, a better understanding of this association is warranted. |
PubMedID- 21308492 | barrett's esophagus is a consequence of gastroesophageal reflux disease. |
PubMedID- 20303354 | Methods: we used esophageal squamous cell lines from patients who had gerd with barrett's esophagus (normal esophageal squamous [nes]-b3t and nes-b10t) and without barrett's esophagus (nes-g2t and nes-g4t) to study effects of acid and bile salts on expression of the cdx2 gene. |
PubMedID- 24795040 | Ppis are prescribed for virtually all patients with barrett's esophagus, irrespective of the presence of reflux symptoms, and represent a de facto chemopreventive agent in this population. |
PubMedID- 25642246 | Pylori and the severity of gerd, including barrett's esophagus, has been demonstrated in epidemiological studies. |
PubMedID- 22194748 | Severe forms of gerd have been associated with barrett's esophagus, which is a form of esophageal metaplasia characterized by aneuploidy (abnormal number of chromosomes) [2]. |
PubMedID- 23407541 | What are predictive factors for developing of barrett's esophagus in patients with gerd-our experience. |
PubMedID- 21476824 | Conclusion: costs due to poorly treated gerd with barrett's esophagus represent a substantial burden for the healthcare systems of all three studied countries. |
PubMedID- 24935200 | The impact of laparoscopic anti-reflux surgery in patients with barrett's esophagus. |
PubMedID- 22919350 | Erosive esophagitis and the complications of gerd, including barrett's esophagus and adenocarcinoma, were less common than in western countries. |
PubMedID- 24867362 | barrett's esophagus (be), a complication of gastroesophageal reflux disease, is associated with an increased risk of esophageal cancer. |
PubMedID- 22844607 | The coexistence of barrett's esophagus with reflux symptoms is considered by many as clear indication for antireflux surgery [112]. |
PubMedID- 23997765 | This might explain their low sensitivity to reflux in patients with barrett's esophagus. |
PubMedID- 26190613 | Although high-grade reflux esophagitis with barrett's esophagus was identified 3 years earlier, he had not visited a hospital for medication. |
PubMedID- 20824377 | Long-term follow-up after anti-reflux surgery in patients with barrett's esophagus. |
PubMedID- 22929214 | Background: the comparative effectiveness (ce) of endoscopic screening (versus no screening) for barrett's esophagus (be) in patients with gerd symptoms, or among different endoscopic surveillance strategies in patients with be, for the early detection of esophageal adenocarcinoma (ea) is unknown. |
PubMedID- 21498395 | For more than three decades, the prevailing clinical paradigm has been that barrett's esophagus is a complication of symptomatic reflux disease that predisposes to esophageal adenocarcinoma. |
Page: 1